Aadi Bioscience Correlations
| AADI Stock | USD 1.80 0.02 1.10% |
The correlation of Aadi Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aadi Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aadi Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Modest diversification
The correlation between Aadi Bioscience and NYA is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aadi Bioscience and NYA in the same portfolio, assuming nothing else is changed.
Aadi |
The ability to find closely correlated positions to Aadi Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aadi Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aadi Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aadi Bioscience to buy it.
Moving together with Aadi Stock
| 0.69 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
| 0.69 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.7 | ZNTL | Zentalis PharmaceuticalsL Financial Report 8th of May 2024 | PairCorr |
| 0.63 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.81 | INZY | Inozyme PharmaInc Financial Report 14th of May 2024 | PairCorr |
| 0.79 | IOVA | Iovance Biotherapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.75 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
| 0.69 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.63 | PHAT | Phathom Pharmaceuticals Financial Report 8th of May 2024 | PairCorr |
| 0.75 | PTGX | Protagonist Therapeutics Financial Report 2nd of May 2024 | PairCorr |
Moving against Aadi Stock
| 0.62 | LPTX | Leap Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.61 | APTO | Aptose Biosciences Financial Report 13th of May 2024 | PairCorr |
| 0.5 | PLRX | Pliant TherapeuticsInc Downward Rally | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aadi Stock performing well and Aadi Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aadi Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ANEB | 2.64 | 0.34 | 0.05 | (0.52) | 3.51 | 6.20 | 20.75 | |||
| ADAG | 5.10 | (0.24) | 0.00 | 0.24 | 0.00 | 10.16 | 32.26 | |||
| ACRV | 6.33 | 1.67 | 0.30 | 1.17 | 4.55 | 17.65 | 73.36 | |||
| ANAB | 2.69 | (0.22) | 0.00 | (0.06) | 0.00 | 5.89 | 22.98 | |||
| MLYS | 2.96 | 0.25 | 0.10 | 0.16 | 3.19 | 6.29 | 24.22 | |||
| ANTX | 4.78 | (2.27) | 0.00 | (1.60) | 0.00 | 3.46 | 77.96 | |||
| AVTE | 4.32 | 0.13 | 0.04 | 0.11 | 4.89 | 11.11 | 28.53 | |||
| GRCL | 3.29 | 1.28 | 0.34 | 0.97 | 2.36 | 8.38 | 61.23 | |||
| THRX | 2.29 | 1.05 | 0.61 | 2.85 | 0.56 | 4.93 | 53.69 | |||
| GLUE | 5.21 | 0.13 | 0.04 | 0.10 | 7.12 | 10.84 | 38.28 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aadi Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Aadi Bioscience Corporate Management
Elected by the shareholders, the Aadi Bioscience's board of directors comprises two types of representatives: Aadi Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aadi. The board's role is to monitor Aadi Bioscience's management team and ensure that shareholders' interests are well served. Aadi Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aadi Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Desai | President, Founder | Profile | |
| Raymond Steitz | Senior Officer | Profile | |
| Bryan Ball | Chief Operations | Profile | |
| Marcy Graham | SVP Communications | Profile | |
| Stephen JD | Senior Counsel | Profile | |
| Brendan MBA | Chief Officer | Profile |
Already Invested in Aadi Bioscience?
The danger of trading Aadi Bioscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aadi Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aadi Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aadi Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.44) | Revenue Per Share 0.905 | Quarterly Revenue Growth 0.21 | Return On Assets (0.28) | Return On Equity (0.50) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.